Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NNNN

Anbio Biotechnology

May 29 • 04:00PM ET

34.41

-0.03 -0.09 %

Healthcare • Medical Instruments & Supplies • Germany • Mid • NASD

Peers: AVTR TFX ICUI BAX BDX RMD MASI EW BSX MDT

Scroll to Statements

Index	-	P/E	210.20	EPS (ttm)	0.16	Insider Own	9.57%	Shs Outstand	43.89M	Perf Week	13.75%
Market Cap	4.95B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	39.69M	Perf Month	25.45%
Enterprise Value	4.94B	PEG	-	EPS next Q	-	Inst Own	0.11%	Short Float	0.23%	Perf Quarter	33.58%
Income	7.19M	P/S	508.35	EPS this Y	-	Inst Trans	0.96%	Short Ratio	3.15	Perf Half Y	58.21%
Sales	9.74M	P/B	42.65	EPS next Y	-	ROA	26.08%	Short Interest	0.09M	Perf YTD	14.43%
Book/sh	0.81	P/C	354.17	EPS next 5Y	-	ROE	27.01%	52W High	55.65 -38.17%	Perf Year	344.00%
Cash/sh	0.10	P/FCF	-	EPS past 3/5Y	-12.86% 23.44%	ROIC	20.29%	52W Low	7.67 348.63%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	761.93	Sales past 3/5Y	-26.67% 16.85%	Gross Margin	87.06%	Volatility	11.65% 10.05%	Perf 5Y	-
Dividend TTM	-	EV/Sales	506.91	EPS Y/Y TTM	170.13%	Oper. Margin	66.47%	ATR (14)	2.98	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	344.31	Sales Y/Y TTM	10.10%	Profit Margin	73.75%	RSI (14)	69.20	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	344.31	EPS Q/Q	321.09%	SMA20	17.73%	Beta	4.37	Target Price	-
Payout	0.00%	Debt/Eq	0.00	Sales Q/Q	87.39%	SMA50	25.47%	Rel Volume	0.28	Prev Close	34.44
Employees	27	LT Debt/Eq	0.00	Earnings	-	SMA200	14.30%	Avg Volume	29.39K	Price	34.41
IPO	Feb 19, 2025	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	8,191	Change	-0.09%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)